Actemra 50242-0137

Generic: Tocilizumab

Product NDC

50242-0137

Manufacturer: Genentech, Inc.
Dosage Form: Injection, Solution, Concentrate
Route: Intravenous
Product Type: Human Prescription Drug
Marketing Start: January 8, 2010
Listing Expires: December 31, 2026
Application: BLA125276

Need to source Actemra? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Tocilizumab	400 mg/20mL

Drug Class

Interleukin-6 Receptor Antagonist [EPC]Interleukin 6 Receptor Antagonists [MoA]Interleukin-6 Receptor Antagonist [EPC]

Packaging Options(1)

50242-0137-01

1 VIAL, SINGLE-USE in 1 BOX (50242-137-01) / 20 mL in 1 VIAL, SINGLE-USE

View →